RUN vs VXRT · P/E 6.0, rev $2.04B vs rev $28.7M
Sunrun Inc (RUN) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
RUN currently screens at market cap $3.05B and trailing P/E 6.0. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the RUN and VXRT stock pages for the full models.
Not investment advice.